Clinical Trial Update: Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a double-masked Phase 3 study of Netarsudil ophthalmic solution in adults with open-angle glaucoma or ocular hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Netarsudil (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2018-04-06